Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sifei Han

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
International Journal of Pharmaceutics|January 24, 2021
Intestinal delivery in a long-chain fatty acid formulation enables lymphatic transport and systemic exposure of orlistatGiven Lee, Sifei Han, Zijun Lu, et al.
Angewandte Chemie (International Ed. in English)|August 3, 2016
Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral BioavailabilityLuojuan Hu, Tim Quach, Sifei Han, et al.
Frontiers in Pharmacology|September 22, 2022
Corrigendum: Triglyceride-mimetic prodrugs of buprenorphine enhance oral bioavailability via promotion of lymphatic transportTim Quach, Luojuan Hu, Sifei Han, et al.
Frontiers in Pharmacology|May 2, 2022
Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic TransportTim Quach, Luojuan Hu, Sifei Han, et al.
Molecular Pharmaceutics|October 19, 2019
Lymphatic Uptake of Liposomes after Intraperitoneal Administration Primarily Occurs via the Diaphragmatic Lymphatics and is Dependent on Liposome Surface PropertiesGiven Lee, Sifei Han, Iasmin Inocencio, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 9, 2014
Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategiesSifei Han, Tim Quach, Luojuan Hu, et al.
Journal of Pharmaceutical Sciences|April 6, 2024
Lymphatic Uptake of a Highly Lipophilic Protease Inhibitor Prodrug from a Lipid-Based Formulation is Limited by Instability in the IntestineYining Xie, Zijun Lu, Ian K Styles, et al.
Molecular Pharmaceutics|February 11, 2025
Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug TransportLuojuan Hu, Tim Quach, Dan Zheng, et al.
Molecular Pharmaceutics|March 30, 2023
Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic AcidSifei Han, Tim Quach, Luojuan Hu, et al.
Journal of Pharmaceutical Sciences|May 28, 2017
Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid FormulationsHywel D Williams, Leigh Ford, Shea Lim, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Pharmaceutics|January 24, 2021
Intestinal delivery in a long-chain fatty acid formulation enables lymphatic transport and systemic exposure of orlistatGiven Lee, Sifei Han, Zijun Lu, et al.
Angewandte Chemie (International Ed. in English)|August 3, 2016
Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral BioavailabilityLuojuan Hu, Tim Quach, Sifei Han, et al.
Frontiers in Pharmacology|September 22, 2022
Corrigendum: Triglyceride-mimetic prodrugs of buprenorphine enhance oral bioavailability via promotion of lymphatic transportTim Quach, Luojuan Hu, Sifei Han, et al.
Frontiers in Pharmacology|May 2, 2022
Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic TransportTim Quach, Luojuan Hu, Sifei Han, et al.
Molecular Pharmaceutics|October 19, 2019
Lymphatic Uptake of Liposomes after Intraperitoneal Administration Primarily Occurs via the Diaphragmatic Lymphatics and is Dependent on Liposome Surface PropertiesGiven Lee, Sifei Han, Iasmin Inocencio, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 9, 2014
Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategiesSifei Han, Tim Quach, Luojuan Hu, et al.
Journal of Pharmaceutical Sciences|April 6, 2024
Lymphatic Uptake of a Highly Lipophilic Protease Inhibitor Prodrug from a Lipid-Based Formulation is Limited by Instability in the IntestineYining Xie, Zijun Lu, Ian K Styles, et al.
Molecular Pharmaceutics|February 11, 2025
Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug TransportLuojuan Hu, Tim Quach, Dan Zheng, et al.
Molecular Pharmaceutics|March 30, 2023
Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic AcidSifei Han, Tim Quach, Luojuan Hu, et al.
Journal of Pharmaceutical Sciences|May 28, 2017
Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid FormulationsHywel D Williams, Leigh Ford, Shea Lim, et al.
Pageof 4